Role of macrophage migration inhibitory factor in age-related lung disease

37Citations
Citations of this article
44Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The prevalence of many common respiratory disorders, including pneumonia, chronic obstructive lung disease, pulmonary fibrosis, and lung cancer, increases with age. Little is known of the host factors that may predispose individuals to such diseases. Macrophage migration inhibitory factor (MIF) is a potent upstream regulator of the immune system. MIF is encoded by variant alleles that occur commonly in the population. In addition to its role as a proinflammatory cytokine, a growing body of literature demonstrates that MIF influences diverse molecular processes important for the maintenance of cellular homeostasis and may influence the incidence or clinical manifestations of a variety of chronic lung diseases. This review highlights the biological properties of MIF and its implication in age-related lung disease.

Author supplied keywords

Cite

CITATION STYLE

APA

Sauler, M., Bucala, R., & Lee, P. J. (2015, July 6). Role of macrophage migration inhibitory factor in age-related lung disease. American Journal of Physiology - Lung Cellular and Molecular Physiology. American Physiological Society. https://doi.org/10.1152/ajplung.00339.2014

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free